Clinical Trial Update: TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating bactericidal activity of multiple oral doses of bedaquiline (TMC207) in adults with sputum smear-positive tuberculosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• TMC207 (bedaquiline) (bedaquiline)

Snippet

Sponsor: Tibotec BVBA | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED